NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
Oncology has a lot on its plate. As cancer care is welcoming a bounty of new treatments, it is absorbing...
Dr. William Flood, Chief Medical Officer for Eviti at NantHealth, discusses new significant findings from Eviti Connect, presented at the...